Pages that link to "Q41478811"

The following pages link to Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line. (Q41478811):

Displaying 45 items.

• X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus (Q24517035) (← links)
• Epstein-Barr virus and Burkitt lymphoma (Q24669890) (← links)
• Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells (Q28295513) (← links)
• Cancer vaccines: novel approaches and new promise (Q33586656) (← links)
• Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer (Q33779343) (← links)
• The effect of viruses on the ability to present antigens via the major histocompatibility complex (Q33797324) (← links)
• The Epstein-Barr virus and its association with human cancers (Q33882153) (← links)
• The immunology of Epstein-Barr virus infection (Q34225567) (← links)
• Immunotherapeutic strategies for EBV-associated malignancies. (Q34265151) (← links)
• Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. (Q34658852) (← links)
• The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies. (Q35036590) (← links)
• Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease (Q35190476) (← links)
• RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. (Q35292814) (← links)
• T cell-based therapies for EBV-associated malignancies (Q35609768) (← links)
• LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. (Q36366222) (← links)
• CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1 (Q36399195) (← links)
• Immune regulation in Epstein-Barr virus-associated diseases (Q36669953) (← links)
• c-MYC impairs immunogenicity of human B cells (Q36786058) (← links)
• A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro (Q37730643) (← links)
• T-Cell Responses to EBV. (Q38597252) (← links)
• Epstein-Barr virus latent membrane protein 2A mediated activation of Sonic Hedgehog pathway induces HLA class Ia downregulation in gastric cancer cells (Q38865839) (← links)
• RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells (Q39682474) (← links)
• Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. (Q39875574) (← links)
• C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma (Q40185161) (← links)
• Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious? (Q40433269) (← links)
• Antigen epitope-expressing cytokines for DNA immunization. (Q40454030) (← links)
• Enhanced tumor immunogenicity through coupling cytokine expression with antigen presentation. (Q40639521) (← links)
• Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. (Q40705440) (← links)
• Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. (Q40804641) (← links)
• Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation (Q40928716) (← links)
• Processing and delivery of peptides presented by MHC class I molecules (Q41053715) (← links)
• Cytotoxic T lymphocyte responses to Epstein-Barr virus (Q41103096) (← links)
• Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. (Q41180520) (← links)
• Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity (Q41342184) (← links)
• Gene Therapy Approaches to Enhance Antitumor Immunity (Q41526902) (← links)
• Modulation of Antigen Processing and Presentation by Persistent Virus Infections and in Tumors (Q41593993) (← links)
• Foulds' Dangerous Idea Revisited: The Multistep Development of Tumors 40 Years Later (Q41617058) (← links)
• Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. (Q41722133) (← links)
• Tumour surveillance: missing peptides and MHC molecules (Q41745124) (← links)
• Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion (Q45737064) (← links)
• Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism (Q45737471) (← links)
• Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression (Q45785307) (← links)
• MHC class I heavy chain mRNA must exceed a threshold level for the reconstitution of cell surface expression of class I MHC complexes in cells transformed by the highly oncogenic adenovirus 12. (Q48010302) (← links)
• Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters. (Q54018506) (← links)
• CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines (Q61788084) (← links)